CN110954702B - 一种血清蛋白hfrep1在类风湿性关节炎疾病状态诊断中的应用 - Google Patents
一种血清蛋白hfrep1在类风湿性关节炎疾病状态诊断中的应用 Download PDFInfo
- Publication number
- CN110954702B CN110954702B CN201911322787.2A CN201911322787A CN110954702B CN 110954702 B CN110954702 B CN 110954702B CN 201911322787 A CN201911322787 A CN 201911322787A CN 110954702 B CN110954702 B CN 110954702B
- Authority
- CN
- China
- Prior art keywords
- diagnosis
- rheumatoid arthritis
- hfrep1
- remission
- patients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
组别 | HFREP1含量(μg/mL) |
类风湿性关节炎活动期患者 | 10.31±16.47 |
类风湿性关节炎缓解期患者 | 0.60±0.42 |
Claims (1)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911322787.2A CN110954702B (zh) | 2019-12-20 | 2019-12-20 | 一种血清蛋白hfrep1在类风湿性关节炎疾病状态诊断中的应用 |
EP20901926.4A EP3929588A4 (en) | 2019-12-20 | 2020-10-21 | APPLICATION OF SERUM PROTEIN HFREP1 IN DIAGNOSIS OF RHEUMATOID ARTHRITIS DISEASE CONDITION |
PCT/CN2020/122351 WO2021120827A1 (zh) | 2019-12-20 | 2020-10-21 | 一种血清蛋白hfrep1在类风湿性关节炎疾病状态诊断中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911322787.2A CN110954702B (zh) | 2019-12-20 | 2019-12-20 | 一种血清蛋白hfrep1在类风湿性关节炎疾病状态诊断中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110954702A CN110954702A (zh) | 2020-04-03 |
CN110954702B true CN110954702B (zh) | 2020-07-10 |
Family
ID=69983056
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911322787.2A Active CN110954702B (zh) | 2019-12-20 | 2019-12-20 | 一种血清蛋白hfrep1在类风湿性关节炎疾病状态诊断中的应用 |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3929588A4 (zh) |
CN (1) | CN110954702B (zh) |
WO (1) | WO2021120827A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110954702B (zh) * | 2019-12-20 | 2020-07-10 | 江苏省中医院 | 一种血清蛋白hfrep1在类风湿性关节炎疾病状态诊断中的应用 |
CN116047082B (zh) * | 2023-01-31 | 2023-09-15 | 江苏品升医学科技有限公司 | 一种fgl1蛋白用于制备诊断慢性肾脏病的试剂盒的用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140051586A1 (en) * | 2011-01-25 | 2014-02-20 | Ignacio Pino | High-throughput methods to produce, validate and characterize mmabs |
CN102393456B (zh) * | 2011-08-24 | 2014-02-12 | 北京正旦国际科技有限责任公司 | 一种用于检测hps的试剂盒 |
CN109959787A (zh) * | 2019-04-18 | 2019-07-02 | 漳州卫生职业学院 | 一种类风湿性关节炎辅助诊断试剂盒及检测方法 |
CN110029168B (zh) * | 2019-05-09 | 2020-02-14 | 山东省立医院 | 基因fgl1在制备结直肠癌和肺癌诊断试剂盒的应用及试剂盒 |
CN110283754B (zh) * | 2019-07-11 | 2021-02-02 | 中国科学院北京基因组研究所 | 用于类风湿关节炎炎症状态评估及预后评价的肠道微生物菌群 |
CN110954702B (zh) * | 2019-12-20 | 2020-07-10 | 江苏省中医院 | 一种血清蛋白hfrep1在类风湿性关节炎疾病状态诊断中的应用 |
-
2019
- 2019-12-20 CN CN201911322787.2A patent/CN110954702B/zh active Active
-
2020
- 2020-10-21 EP EP20901926.4A patent/EP3929588A4/en active Pending
- 2020-10-21 WO PCT/CN2020/122351 patent/WO2021120827A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2021120827A1 (zh) | 2021-06-24 |
EP3929588A4 (en) | 2022-07-13 |
CN110954702A (zh) | 2020-04-03 |
EP3929588A1 (en) | 2021-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112017783A (zh) | 一种心脏术后肺部感染的预测模型及其构建方法 | |
CN110954702B (zh) | 一种血清蛋白hfrep1在类风湿性关节炎疾病状态诊断中的应用 | |
US10422004B2 (en) | Diagnostic method for distinguishing forms of esophageal eosinophilia | |
MacGregor | Classification criteria for rheumatoid arthritis | |
CN117288963B (zh) | 一种hfrep1蛋白用于制备诊断急性心肌梗死、脑梗死的试剂盒的用途 | |
RU2583939C1 (ru) | Способ лабораторной диагностики стадии фиброза печени при хроническом вирусном гепатите с | |
CN104198693A (zh) | 一种t淋巴细胞的酶联免疫斑点试验方法 | |
CN110161235B (zh) | 三种血清蛋白联合用于强直性脊柱炎诊断的用途 | |
CN113125615B (zh) | 三种代谢标志物单独或联合在制备诊断系统性红斑狼疮的试剂盒方面的应用 | |
CN112037931B (zh) | 在疑似原发性醛固酮增多症中应用的醛固酮增多预测体系 | |
CN113495137A (zh) | 两种代谢标志物单独或联合在制备诊断克罗恩病的试剂盒中的应用 | |
Levay et al. | Causes of high erythrocyte sedimentation rates in an inpatient population | |
CN116047082B (zh) | 一种fgl1蛋白用于制备诊断慢性肾脏病的试剂盒的用途 | |
CN118688456A (zh) | Fgl1蛋白在制备诊断肺炎的试剂盒中的应用 | |
RU2817079C1 (ru) | Способ дифференциальной диагностики системной красной волчанки и болезни Шегрена | |
CN116679042A (zh) | 一种fgl1蛋白用于制备诊断急性胰腺炎的试剂盒的用途 | |
CN118566509A (zh) | 一种fgl1蛋白在制备诊断湿疹或荨麻疹的试剂盒中的应用 | |
CN114383911B (zh) | 甘氨脱氧胆酸用于制备诊断心力衰竭的试剂盒的用途 | |
Azalan et al. | Association of New Generation Anti-CCP Antibodies with Disease Severity and Functional Status in Rheumatoid Arthritis Patients. | |
Qingmei et al. | Clinical significance of combined anti-cyclic citrullinated peptide antibody and rheumatoid factor assays in rheumatoid arthritis diagnosis | |
CN112903840B (zh) | 一种血清代谢物用于制备诊断干燥综合征的试剂盒的用途 | |
CN106520916A (zh) | lncRNA‑MIR3945HG V2在菌阴肺结核诊断中的应用 | |
CN112881668B (zh) | 两种血清代谢物单独或联合用于制备诊断干燥综合征的试剂盒的用途 | |
Cao et al. | The relationship between serum CXCL1 and PTEN mRNA levels and disease severity and prognosis in patients with acute cerebral infarction | |
CN118258989A (zh) | 高迁移率族蛋白1检测试剂盒及其检测方法、强直性脊柱炎患者治疗后评估方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201023 Address after: Room 1403, building e07-2, 272 Jiqingmen street, Gulou District, Nanjing, Jiangsu Province, 210009 Patentee after: Nanjing jiahuang Biotechnology Co., Ltd Address before: 210029 No. 155, Hanzhoung Road, Nanjing, Jiangsu Patentee before: JIANGSU PROVINCIAL HOSPITAL OF TCM Patentee before: CHINA PHARMACEUTICAL University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210615 Address after: No.7 Shengshui Road, Lishui Economic Development Zone, Nanjing, Jiangsu, 211200 Patentee after: Jiangsu Pinsheng Medical Technology Co.,Ltd. Address before: 210009 room 1403, building e07-2, 272 Jiqingmen street, Gulou District, Nanjing City, Jiangsu Province Patentee before: Nanjing jiahuang Biotechnology Co., Ltd |
|
TR01 | Transfer of patent right |